News in the Life Sciences Industry

HUDDINGE, Sweden, May 5, 2020 /PRNewswire/ -- Positive results for MIV-818 and continued tempo in business development

STOCKHOLM, May 5, 2020 /PRNewswire/ -- First quarter

OSLO, Norway, May 4, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) today announces changes to its Executive Management Team.

STOCKHOLM, May 4, 2020 /PRNewswire/ -- The initial safety and dose escalation part of the Phase I/II trial ReGenerate-1 with Remygen(®) in individuals with long-term type 1 diabetes today presents preliminary results showing that the trial participants' blood sugar control improved over... Read more ››

OSLO, Norway, May 4, 2020 /PRNewswire/ -- Targovax ASA (OSE: TRVX), a clinical stage immuno-oncology company developing oncolytic viruses to target hard-to-treat solid tumors, today releases an update from the randomized phase I/II trial of ONCOS-102 in combination with standard... Read more ››

HELSINKI, May 4, 2020 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has been awarded a Good Manufacturing Practices (GMP) certification by the Finnish Medicines Agency, FIMEA. Achieving GMP status permits Nanoform to manufacture an investigational... Read more ››

STOCKHOLM, May 4, 2020 /PRNewswire/ -- SciBase (SCIB) announced today, on "Melanoma Monday", that they have entered into a collaboration agreement with Advanced Dermatology and Cosmetic Surgery ("ADCS") - the premier dermatology network in the US with over 150 practices. The agreement will provide... Read more ››

STOCKHOLM, May 4, 2020 /PRNewswire/ -- Cantargia AB today announced that the IND application regarding the antibody CAN04 has been approved by the US FDA. CAN04, an antibody targeting interleukin 1 receptor accessory protein (IL1RAP), is currently being investigated for treatment of non-small... Read more ››